SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.
作者信息
Ye Qing, Lai En Yin, Luft Friedrich C, Persson Pontus B, Mao Jianhua
机构信息
National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China.
出版信息
Acta Physiol (Oxf). 2021 Apr;231(4):e13608. doi: 10.1111/apha.13608. Epub 2021 Jan 7.
Abstract
摘要
相似文献
1
SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.严重急性呼吸综合征冠状病毒2对肾素-血管紧张素-醛固酮系统的影响及治疗意义
Acta Physiol (Oxf). 2021 Apr;231(4):e13608. doi: 10.1111/apha.13608. Epub 2021 Jan 7.
2
The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.新型冠状病毒肺炎中肾素-血管紧张素-醛固酮系统抑制剂的困境：权衡心血管益处与病毒风险
Hypertens Res. 2024 Sep;47(9):2598-2600. doi: 10.1038/s41440-024-01772-x. Epub 2024 Jul 1.
3
The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.在新冠肺炎患者中使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的争议。
J Renin Angiotensin Aldosterone Syst. 2021 Jan-Dec;22(1):1470320320987118. doi: 10.1177/1470320320987118.
4
The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.新型冠状病毒肺炎中肾素-血管紧张素-醛固酮系统抑制剂：从酸中毒到通气与免疫
Swiss Med Wkly. 2020 Dec 11;150:w20444. doi: 10.4414/smw.2020.20444. eCollection 2020 Nov 30.
5
COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?新型冠状病毒肺炎、高血压与肾素-血管紧张素-醛固酮系统抑制剂：小题大做还是亟待解决的实际问题？
J Clin Hypertens (Greenwich). 2020 Nov;22(11):1984-1986. doi: 10.1111/jch.14045. Epub 2020 Sep 20.
6
Cardiovascular disease and the impact of COVID-19.心血管疾病与2019冠状病毒病的影响
J Card Surg. 2020 Aug;35(8):2113. doi: 10.1111/jocs.14682. Epub 2020 Jun 16.
7
What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.实体器官移植医护人员应该了解的肾素-血管紧张素-醛固酮系统抑制剂与 COVID-19 相关知识。
Clin Transplant. 2020 Jul;34(7):e13991. doi: 10.1111/ctr.13991. Epub 2020 Jun 15.
8
COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.2019冠状病毒病、高血压与肾素-血管紧张素-醛固酮系统阻滞剂：BRACE-CORONA试验
Cardiovasc Res. 2020 Dec 1;116(14):e198-e199. doi: 10.1093/cvr/cvaa325.
9
Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎患者的预后：一项病例系列研究。
Hypertension. 2020 Aug;76(2):e10-e12. doi: 10.1161/HYPERTENSIONAHA.120.15312. Epub 2020 May 8.
10
A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎关系的Meta分析
Am J Cardiol. 2020 Sep 1;130:159-161. doi: 10.1016/j.amjcard.2020.05.038. Epub 2020 Jun 2.
引用本文的文献
1
Biological characteristics of SARS-CoV-2 resistant populations by integrated gut microbiota sequencing, metabolomics, and proteomics: a cohort comparison study.通过整合肠道微生物群测序、代谢组学和蛋白质组学分析SARS-CoV-2抗性人群的生物学特征：一项队列比较研究
Front Med (Lausanne). 2025 Jul 7;12:1593007. doi: 10.3389/fmed.2025.1593007. eCollection 2025.
2
A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2.分段设计方法工程化 ACE2 类似物以结合 SARS-CoV-2
ACS Appl Bio Mater. 2024 May 20;7(5):3238-3246. doi: 10.1021/acsabm.4c00222. Epub 2024 May 3.
3
Immunomodulatory Effects of Vitamin D in Respiratory Tract Infections and COVID-19 in Children.维生素 D 对儿童呼吸道感染和 COVID-19 的免疫调节作用。
Nutrients. 2023 Aug 2;15(15):3430. doi: 10.3390/nu15153430.
4
Nonpharmaceutical interventions for COVID-19 disrupt the dynamic balance between influenza A virus and human immunity.针对 COVID-19 的非药物干预措施打破了甲型流感病毒和人类免疫力之间的动态平衡。
J Med Virol. 2023 Jan;95(1):e28292. doi: 10.1002/jmv.28292. Epub 2022 Nov 23.
5
Nucleic Acid Vaccines against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的核酸疫苗
Vaccines (Basel). 2022 Oct 31;10(11):1849. doi: 10.3390/vaccines10111849.
6
Omicron variant: Current insights and future directions.奥密克戎变异株：当前的认识和未来方向。
Microbiol Res. 2022 Dec;265:127204. doi: 10.1016/j.micres.2022.127204. Epub 2022 Sep 17.
7
Accurate Interpretation of SARS-CoV-2 Antigen Detection by Immunochromatography.免疫层析法对新型冠状病毒抗原检测的准确解读
Front Med (Lausanne). 2022 Jun 29;9:949554. doi: 10.3389/fmed.2022.949554. eCollection 2022.
8
Performance and application evaluation of SARS-CoV-2 antigen assay.新型冠状病毒抗原检测试剂的性能评估和应用评价。
J Med Virol. 2022 Aug;94(8):3548-3553. doi: 10.1002/jmv.27798. Epub 2022 Apr 30.
9
The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant.高度变异的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变异株的出现及流行特征
J Med Virol. 2022 Jun;94(6):2376-2383. doi: 10.1002/jmv.27643. Epub 2022 Feb 11.
10
Getting it right matters! Covid-19 pandemic analogies to everyday life in medical sciences.做对至关重要！新冠疫情与医学科学中的日常生活类比。
Acta Physiol (Oxf). 2021 Sep;233(1):e13714. doi: 10.1111/apha.13714. Epub 2021 Jul 14.
本文引用的文献
1
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征：一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
2
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.工程改造人血管紧张素转换酶 2 以优化其与严重急性呼吸综合征冠状病毒 2 刺突蛋白的结合。
Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4.
3
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.美国心力衰竭学会/美国心脏病学会/美国心脏协会联合声明回应关于在2019冠状病毒病中使用肾素-血管紧张素-醛固酮系统拮抗剂的担忧。
J Card Fail. 2020 May;26(5):370. doi: 10.1016/j.cardfail.2020.04.013.
4
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient.从 COVID-19 患者尿液中分离出传染性 SARS-CoV-2。
Emerg Microbes Infect. 2020 Dec;9(1):991-993. doi: 10.1080/22221751.2020.1760144.
5
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
6
Reactive oxygen species in renal vascular function.肾脏血管功能中的活性氧物质。
Acta Physiol (Oxf). 2020 Aug;229(4):e13477. doi: 10.1111/apha.13477. Epub 2020 May 8.
7
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
8
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
9
Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.血管紧张素2型受体基因敲除小鼠的肾血管紧张素2型受体/血管紧张素（1-7）/Mas受体水平降低，且在高脂饮食诱导下表现出更严重的肾损伤。
J Renin Angiotensin Aldosterone Syst. 2016 Aug 5;17(3). doi: 10.1177/1470320316661871. Print 2016 Jul.
10
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4.MERS-CoV 刺突受体结合域与人受体 DPP4 复合物的结构。
Cell Res. 2013 Aug;23(8):986-93. doi: 10.1038/cr.2013.92. Epub 2013 Jul 9.
Zotero 插件